# Tyra Biosciences, Inc.: Form 8-K, filed May 31, 2024

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: 8-K
- Filed: 2024-05-31
- Accepted by EDGAR: May 31, 2024, 16:02 ET
- Period: 2024-05-29
- Accession: 0001193125-24-151705
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/d807421d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/d807421d8k.htm

Filed May 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-151705. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
